Cargando…
The development of live biotherapeutics against Clostridioides difficile infection towards reconstituting gut microbiota
Clostridioides difficile is the most prevalent pathogen of nosocomial diarrhea. In the United States, over 450,000 cases of C. difficile infection (CDI), responsible for more than 29,000 deaths, are reported annually in recent years. Because of the emergence of hypervirulent strains and strains less...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Taylor & Francis
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959509/ https://www.ncbi.nlm.nih.gov/pubmed/35319337 http://dx.doi.org/10.1080/19490976.2022.2052698 |